The company in question is, Allergan plc (NYSE:AGN) currently with a stock price of 248.95 (0.45% today). The market cap for Allergan plc is 98722.11, and is in the sector Healthcare, and Drugs – Generic industry. The target price for Allergan plc is 293.06. Currently Allergan plc is trading with a P/E of *TBA, and a forward P/E of 14.32. Average volume for Allergan plc is 3555.73 and so far today it is 948462.
Performance in the last year for Allergan plc has been -21.41%. For EPS growth, Allergan plc has seen a growth of 23.00%, and is looking to grow in the next year to 21.91%. More long term stats show that EPS growth has been -50.40% over the last five years and could be 9.70% for the next five years. Allergan plc has seen sales growth quarter over quarter at 48.10%, with EPS growth quarter over quarter at 86.30%. The 20-day simple moving average is 5.56%, with the 200-day simple moving average coming to -7.45%.
Since the IPO date for Allergan plc on the 2/17/1993, Allergan plc has seen performance year to date to be -20.69%. With Allergan plc trading at 248.95, the dividend yield is 0.08%, and the EPS is -5.63.
So could Allergan plc, be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 6.05 and the P/B is at 1.35. The P/cash is 43.42, with P/free cash flow at *TBA.
Allergan plc ability to deal with debt shows that the current ratio is 1, and the quick ratio is 0.9. This is with long term debt/equity at 0.53, and total debt/equity at 0.59.
In terms of margins, Allergan plc has a gross margin of 71.80%, an operating margin of *TBA and a profit margin of *TBA.Payout ratio for Allergan plc is *TBA. Return on assets come to *TBA with return on investment coming to -1.30%.
Insider ownership for Allergan plc, is at 0.10% and institutional ownership comes to 89.90%. Outstanding shares are at 398.33. While shares float is 394.89. The float short is currently 1.47%, and short ratio is 1.63.